Startseite A novel nonsense mutation in the WFS1 gene causes the Wolfram syndrome
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

A novel nonsense mutation in the WFS1 gene causes the Wolfram syndrome

  • Shahab Noorian EMAIL logo , Shahram Savad und Davood Shah Mohammadi
Veröffentlicht/Copyright: 4. März 2016

Abstract

Wolfram syndrome is a rare autosomal recessive neurodegenerative disorder, which is mostly caused by mutations in the WFS1 gene. The WFS1 gene product, which is called wolframin, is thought to regulate the function of endoplasmic reticulum. The endoplasmic reticulum has a critical role in protein folding and material transportation within the cell or to the surface of the cell. Identification of new mutations in WFS1 gene will unravel the molecular pathology of WS. The aim of this case report study is to describe a novel mutation in exon 4 of the WFS1 gene (c.330C>A) in a 9-year-old boy with WS.


Corresponding author: Shahab Noorian, Department of Pediatric Endocrinology Metabolism, Bahonar Hospital, Alborz University of Medical sciences, Karaj, Iran, E-mail:

References

1. Eiberg H, Hansen L, Kjer B, Hansen T, Pedersen O, et al. Autosomal dominant optic atrophy associated with hearing impairment and impaired glucose regulation caused by a missense mutation in the WFS1 gene. J Med Genet 2006;43:435–40.10.1136/jmg.2005.034892Suche in Google Scholar

2. Strom TM, Hortnagel K, Hofmann S, Gekeler F, Scharfe C, et al. Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (Wolframin) coding for a predicted transmembrane protein. Hum Mol Genet 1998;7:2021–8.10.1093/hmg/7.13.2021Suche in Google Scholar

3. Ghirardello S, Garrè ML, Rossi A, Maghnie M. The diagnosis of children with central diabetes insipidus pathology. J Pediatr Endocrinol Metab 2007;20:359–76.10.1515/JPEM.2007.20.3.359Suche in Google Scholar

4. Najjar SS, Saikaly MG, Zaytoun GM, Abdelnoor A. Association of diabetes insipidus, diabetes mellitus, optic atrophy, and deafness. The Wolfram or DIDMOAD syndrome. Arch Dis Child 1985;60:823–8.10.1136/adc.60.9.823Suche in Google Scholar

5. Fonseca SG, Burcin M, Gromada J, Urano F. Endoplasmic reticulum stress in beta cells and development of diabetes. Curr Opin Pharmacol 2009;9:763–70.10.1016/j.coph.2009.07.003Suche in Google Scholar

6. Barrett TG, Bundey SE, Macleod AF. Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome. Lancet 1995;346:1458–63.10.1016/S0140-6736(95)92473-6Suche in Google Scholar

7. Norooziasl S, Javadinia SA. A case report of Wolfram syndrome. J Birjand Univ Med Sci 2013;20:102–7. [In Persian].Suche in Google Scholar

8. Çamtosun E, Şıklar Z, Kocaay P, Ceylaner S, Flanagan SE, et al. Three cases of Wolfram syndrome with different clinical aspects. J Pediatr Endocrinol Metab 2015;28:433–8.10.1515/jpem-2014-0139Suche in Google Scholar PubMed

9. Pitt K, James C, Kochar IS, Kapoor A, Jain S, et al. A single base-pair deletion in the WFS1 gene causes Wolfram syndrome. J Pediatr Endocrinol Metab 2011;24:389–91.10.1515/jpem.2011.215Suche in Google Scholar PubMed

Received: 2015-2-1
Accepted: 2015-12-30
Published Online: 2016-3-4
Published in Print: 2016-5-1

©2016 by De Gruyter

Artikel in diesem Heft

  1. Frontmatter
  2. Review
  3. Resistance to thyroid hormone α, revelation of basic study to clinical consequences
  4. Original Articles
  5. Improved molecular diagnosis of patients with neonatal diabetes using a combined next-generation sequencing and MS-MLPA approach
  6. Safety and metabolic impact of Ramadan fasting in children and adolescents with type 1 diabetes
  7. Waist-to-height ratio as a marker of low-grade inflammation in obese children and adolescents
  8. Classification and clinical characterization of metabolically “healthy” obese children and adolescents
  9. Long-term BH4 (sapropterin) treatment of children with hyperphenylalaninemia – effect on median Phe/Tyr ratios
  10. Compound heterozygous mutations (p.T561M and c.2422delT) in the TPO gene associated with congenital hypothyroidism
  11. Prevalence and clinical features of polycystic ovarian syndrome in adolescents with previous childhood growth hormone deficiency
  12. Urate crystals deposition in the feet of overweight juveniles and those with symptomatic hyperuricemia: a dual-energy CT study
  13. A novel ALMS1 homozygous mutation in two Turkish brothers with Alström syndrome
  14. Novel AVPR2 mutation causing partial nephrogenic diabetes insipidus in a Japanese family
  15. Pituitary gigantism: a retrospective case series
  16. Case Reports
  17. A novel OTX2 gene frameshift mutation in a child with microphthalmia, ectopic pituitary and growth hormone deficiency
  18. A novel nonsense mutation in the WFS1 gene causes the Wolfram syndrome
  19. A 33-year-old male patient with paternal derived duplication of 14q11.2–14q22.1~22.3: clinical course, phenotypic and genotypic findings
  20. Familial Turner syndrome: the importance of information
  21. De novo mutation of PHEX in a type 1 diabetes patient
  22. Congenital hypothyroidism and thyroid dyshormonogenesis: a case report of siblings with a newly identified mutation in thyroperoxidase
Heruntergeladen am 19.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2015-0045/html
Button zum nach oben scrollen